Total Payments
$9,325
2024 Payments
$876.92
Companies
26
Transactions
429
Medicare Patients
3,700
Medicare Billing
$382,187
Payment Breakdown by Category
Food & Beverage$8,976 (96.3%)
Education$348.19 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,976 | 413 | 96.3% |
| Education | $348.19 | 16 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,426 | 175 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,188 | 78 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $806.27 | 38 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $684.16 | 37 | $0 (2024) |
| United Therapeutics Corporation | $330.26 | 15 | $0 (2023) |
| Insmed, Inc. | $284.14 | 16 | $0 (2023) |
| GENZYME CORPORATION | $238.38 | 7 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $186.17 | 10 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $131.08 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $111.31 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $876.92 | 38 | GlaxoSmithKline, LLC. ($569.76) |
| 2023 | $1,516 | 74 | Actelion Pharmaceuticals US, Inc. ($423.51) |
| 2022 | $1,383 | 63 | GlaxoSmithKline, LLC. ($393.57) |
| 2021 | $1,105 | 49 | GlaxoSmithKline, LLC. ($484.01) |
| 2020 | $1,126 | 59 | GlaxoSmithKline, LLC. ($317.02) |
| 2019 | $1,365 | 49 | GlaxoSmithKline, LLC. ($605.87) |
| 2018 | $910.11 | 50 | GlaxoSmithKline, LLC. ($402.75) |
| 2017 | $1,043 | 47 | AstraZeneca Pharmaceuticals LP ($336.12) |
All Payment Transactions
429 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.02 | General |
| 12/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.53 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $103.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $39.86 | General |
| 10/07/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $27.17 | General |
| 10/02/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $131.10 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Cardiology | ||||||
| 08/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Cardiology | ||||||
| 08/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: RESPIRATORY | ||||||
| 08/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Respiratory | ||||||
| 06/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 859 | 1,310 | $249,550 | $93,192 |
| 2022 | 15 | 937 | 1,380 | $280,505 | $97,073 |
| 2021 | 16 | 936 | 1,394 | $255,642 | $90,581 |
| 2020 | 17 | 968 | 1,486 | $285,130 | $101,340 |
Total Patients
3,700
Total Services
5,570
Medicare Billing
$382,187
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 332 | $69,720 | $30,283 | 43.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 163 | 190 | $47,500 | $18,765 | 39.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 101 | 226 | $33,900 | $13,682 | 40.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 84 | 148 | $33,300 | $13,484 | 40.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 38 | 38 | $15,770 | $5,894 | 37.4% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 28 | 33 | $19,800 | $2,842 | 14.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 101 | 106 | $10,070 | $1,956 | 19.4% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 17 | 20 | $8,000 | $1,345 | 16.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 28 | 35 | $3,500 | $1,338 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 20 | $2,940 | $1,280 | 43.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 38 | $1,520 | $1,102 | 72.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 40 | 40 | $1,550 | $832.20 | 53.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 39 | $1,755 | $385.07 | 21.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 13 | 45 | $225.00 | $4.42 | 2.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 356 | $74,760 | $32,004 | 42.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 131 | 152 | $41,045 | $15,542 | 37.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 85 | 190 | $38,950 | $14,796 | 38.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 90 | 178 | $24,930 | $9,646 | 38.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 43 | 43 | $17,845 | $6,465 | 36.2% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 42 | 42 | $11,550 | $4,242 | 36.7% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2022 | 28 | 34 | $23,700 | $2,940 | 12.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 140 | 149 | $14,155 | $2,590 | 18.3% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 35 | 35 | $14,000 | $2,322 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 34 | $4,995 | $2,280 | 45.7% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 18 | 25 | $3,625 | $1,375 | 37.9% |
About Fadi Malek, M.D. F.C.C.P
Fadi Malek, M.D. F.C.C.P is a Pulmonary Disease healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699761056.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Fadi Malek, M.D. F.C.C.P has received a total of $9,325 in payments from pharmaceutical and medical device companies, with $876.92 received in 2024. These payments were reported across 429 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($8,976).
As a Medicare-enrolled provider, Malek has provided services to 3,700 Medicare beneficiaries, totaling 5,570 services with total Medicare billing of $382,187. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Lafayette, LA
- Active Since 09/21/2005
- Last Updated 05/26/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1699761056
Products in Payments
- NUCALA (Biological) $1,230
- TRELEGY ELLIPTA (Drug) $1,183
- DUPIXENT (Biological) $902.87
- ANORO (Drug) $438.88
- OPSUMIT (Drug) $392.56
- SYMBICORT (Drug) $366.52
- BREZTRI (Drug) $308.78
- UPTRAVI (Drug) $301.99
- FASENRA (Biological) $287.74
- FASENRA (Drug) $282.00
- Arikayce (Drug) $267.90
- BREO (Drug) $232.68
- ORENITRAM (Drug) $225.56
- BEVESPI AEROSPHERE (Drug) $216.63
- AIRSUPRA (Drug) $148.54
- ANORO ELLIPTA (Drug) $142.84
- TEZSPIRE (Biological) $137.96
- UTIBRON (Drug) $131.49
- AREXVY (Drug) $131.10
- OPSUMIT MACITENTAN (Drug) $122.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Lafayette
Mr. Walter Brown, Md, MD
Pulmonary Disease — Payments: $12,452
Pulmonary Disease $12,452
Mr. George Guidry, Md, MD
Pulmonary Disease — Payments: $11,149
Pulmonary Disease $11,149
Timothy Keys, M.d, M.D
Pulmonary Disease — Payments: $10,588
Pulmonary Disease $10,588
Justin Ardoin, M.d, M.D
Pulmonary Disease — Payments: $8,447
Pulmonary Disease $8,447
Richard Fei, M.d. F.c.c.p, M.D. F.C.C.P
Pulmonary Disease — Payments: $5,969
Pulmonary Disease $5,969
Mehboob Kalani, Md, MD
Pulmonary Disease — Payments: $5,488
Pulmonary Disease $5,488